Michael Egholm - Apr 4, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
President & CEO, Director
Signature
/s/ Michael Egholm by Nicholas Khadder, Attorney-in-Fact
Stock symbol
LAB
Transactions as of
Apr 4, 2022
Transactions value $
$0
Form type
4
Date filed
4/6/2022, 06:35 PM
Previous filing
Oct 7, 2021
Next filing
Jun 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Award $0 +786K $0.00 786K Apr 4, 2022 Common Stock 786K Direct F1, F2
transaction LAB Stock Option (Right to Buy) Award $0 +4.53M $0.00 4.53M Apr 4, 2022 Common Stock 4.53M $3.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
F2 Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.
F3 The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter.